Asacol
Indicated for ulcerative colitis and formulated to mitigate inflammation.
Strengths: 400mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Octasa; Salofalk; Mezavant
- Therapeutic class
Aminosalicylate
- Pharmacological class
Anti-inflammatory
- Known off-label uses
crohn's disease
- Minor side effects
headache; nausea; diarrhoea
- Moderate side effects
rash; abdominal pain; arthralgia
- Dosage forms
Gastro-resistant tablet
- Administration route
Oral use
- Patient summary
Indicated for ulcerative colitis and formulated to mitigate inflammation.
- Prescription status
POM
- Manufacturer
Tillotts Pharma
- Onset Time
1–2 weeks
- Duration
Ongoing treatment
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
azathioprine; mercaptopurine
- Age restrictions
Consult physician for use in children.
- Pregnancy and breastfeeding
Discuss with doctor; generally considered safe but monitoring advised.
Contraindications
hypersensitivity to salicylates; severe renal impairment; severe hepatic impairment
Precautions and warnings
monitor renal function periodically; use with care in patients with active peptic ulcer
Serious side effects
nephrotoxicity — requires immediate medical attention; blood dyscrasias — requires immediate medical attention
Mechanism of action
Mesalazine exerts a local anti-inflammatory effect on the intestinal mucosa, likely by inhibiting cyclooxygenase and lipoxygenase, thereby decreasing the production of prostaglandins and leukotrienes.
Asacol
Indicated for ulcerative colitis and formulated to mitigate inflammation.
Editorial Notes
- Active ingredient(s): Mesalazine
- Listed indication(s): Ulcerative Colitis
Available option
- 90 tablets - 400 mg370-400-mg-2100